Bicara Therapeutics CMO David Raben sells $125,830 in shares
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- US mandates what it calls ’enhanced’ security checks for immigration applicants
- US Senate blocks bid to prevent Trump from military action against Cuba
- US seeks new nominees for key preventive health panel
- At his OpenAI trial, Musk relitigates an old friendship
- Earnings call transcript: Aeris Resources Q3 2026 sees strong cash flow growth
- Brazilian regulator probes airlines LATAM, Gol over potential price alignment
News from Other Countries
🇬🇧 United Kingdom
- Billie Eilish puts Manchester at centre of new 3D concert film
- Early care scheme could prevent thousands of miscarriages a year
- A record-breaking semi-final - the antidote to modern football?